A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma

NCT01479595 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: QBX258
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals